Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Bladder cancer

Lack of progress in bladder cancer—what are the obstacles?

Nature Reviews Urology volume 10, pages5–6(2013)Cite this article

Subjects

Research has revealed what we already suspected—randomized controlled trials are lacking in the field of bladder cancer. Many areas require further investigation, and we must try to incentivize clinicians to perform the much-needed trials. A newly established patient advocacy group will be invaluable in this endeavour.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

Rent or Buy

All prices are NET prices.

References

  1. 1

    Bachir, B. G. et al. Demographic analysis of randomized controlled trials in bladder cancer. BJU Int. http://dx.doi.org/10.1111/j.1464-410X.2012.11401.x.

  2. 2

    Jemal, A. et al. Cancer Statistics, 2008. CA Cancer J. Clin. 58, 71–96 (2008).

    Google Scholar 

  3. 3

    Ries, L. A. G. et al. SEER Cancer Statistics Review, 1975–2004 [online], (2007).

  4. 4

    Heney, N. M. et al. Superficial bladder cancer: progression and recurrence. J. Urol. 130, 1083–1086 (1983).

    CAS  Article  PubMed  Google Scholar 

  5. 5

    Lotan, Y. et al. Key concerns about the current state of bladder cancer: a position paper from the Bladder Cancer Think Tank, the Bladder Cancer Advocacy Network, and the Society of Urologic Oncology. Cancer 115, 4096–4103 (2009).

    Article  PubMed  Google Scholar 

  6. 6

    Soloway, M. S., Bruck, D. S. & Kim, S. S. Expectant management of small, recurrent, noninvasive papillary bladder tumors. J. Urol. 170, 438–441 (2003).

    Article  PubMed  Google Scholar 

  7. 7

    Herr, H. W. Does cystoscopy correlate with the histology of recurrent papillary tumours of the bladder? BJU Int. 88, 683–685 (2001).

    CAS  Article  PubMed  Google Scholar 

  8. 8

    Babjuk, M. et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur. Urol. 54, 303–314 (2008).

    Article  PubMed  Google Scholar 

  9. 9

    Schmitz-Drager, B. J. et al. in Bladder Cancer 2nd Edn (eds Soloway, M. & Khoury, S.) 171–205 (European Association of Urology, Paris, 2012).

    Google Scholar 

Download references

Author information

Affiliations

  1. Department of Urology, University of Miami Miller School of Medicine, PO Box 016960 (M814), Miami, 33103, FL, USA

    Mark S. Soloway

Authors
  1. Mark S. Soloway
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares he has acted as a consultant and received grant/research support (inc. clinical trials) from Allergan, Photocure and Sanofi-Aventis.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Soloway, M. Lack of progress in bladder cancer—what are the obstacles?. Nat Rev Urol 10, 5–6 (2013). https://doi.org/10.1038/nrurol.2012.219

Download citation

Further reading

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing